 |
|
|
|
|
New Mexico Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing New MexicoLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Exagen Diagnostics Inc.
| | | | | Phone: | (505) 272-7966 | | Fax: | (505) 272-7965 | | Year Established: | 2002 | | Employees: | 30 | | Main Contact: | Dennis Takasugi, VP Business Development | | | | Other Contacts: | John Wegener, VP, Sales & Managed Markets
Claudia Ibarra, VP, Laboratory Operations
Wendy Swedick, CPA, Executive VP & CFO
Thierry Dervieux, Ph.D., CSO & CMO
Ron Rocca, President & CEO
| | | | Company Description | | Exagen is focused on the development of prognostic and predictive in vitro diagnostic (IVD) kits, and is able to discover, and validate small sets of genomic markers for use in oncology, infectious disease and other indications. The company’s first tests predict the risk of breast cancer recurrence, so that women with a low or elevated risk of
recurrence can be identified with high accuracy. Exagen plans to submit its
tests to the Food and Drug Administration for clearance later this year, and
will be the first to market a set of genomic markers for breast cancer
prognosis using a fluorescent in situ hybridization (FISH) test. | |
|
|
|
|
|
|
|
